DBV Technologies (DBVT) Return on Invested Capital (2021)
DBV Technologies (DBVT) posted quarterly Return on Invested Capital of 2.21% for Q1 2021.
DBV Technologies (DBVT) Return on Invested Capital (2021) Analysis & Trends
DBV Technologies (DBVT) has reported Return on Invested Capital for 1 consecutive years, with 2.21% the latest figure, recorded in Q1 2021.
- Quarterly Return on Invested Capital changed N/A year-over-year to 2.21% in Q1 2021, while the trailing twelve-month figure through Mar 2021 was 2.21% (changed N/A YoY) and the FY2019 annual result came in at 0.03%, up 1.0% from the prior year.
- Return on Invested Capital was little changed at 2.21% in Q1 2021 per DBVT's latest filing.
- Over the last five years, Return on Invested Capital for DBVT reached as high as 2.21% in Q1 2021 and fell as low as 2.21% in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.04% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | DBV Technologies | 267.50 Mn | 92.60 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | -2.21% |